Results 241 to 250 of about 38,942 (318)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis

, 2011
UrmiN Shah, NikunjJ Shah
openalex   +1 more source

Safety Evaluation of Bilateral Same-Day Intravitreal Injection of Faricimab. [PDF]

Ophthalmol Ther
Karampelas MD, Chatziralli IP, Karagiannis DA.   +2 more
europepmc   +1 more source

Systematic review and sequential analysis of traditional Chinese medicine in the treatment of age-related macular degeneration based on GRADE evidence quality rating. [PDF]

Medicine (Baltimore)
Liu J, Huang Y, Dong Z, Qian C, Huang B.
europepmc   +1 more source

Treatment Regimens with Ranibizumab in Neovascular Age-Related Macular Degeneration: Real-World Results from the PACIFIC Study. [PDF]

Clin Ophthalmol
Lorenz K, Haritoglou C, Barthelmes D, Sefat AMM, Berk H, Beeke E, Scheffler M, Iwersen M, Müller B, Ziemssen F, members of the PACIFIC study group.   +10 more
europepmc   +1 more source

Antiangiogenic Drugs in Age Related Macular Degeneration: evidence based medicine and off-label use [PDF]

, 2011
Cachulo, ML, Faria de Abreu, JR, Figueira, J, Fonseca, P, Murta, JN, Pires, I, Silva, R   +6 more
core  

Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD. [PDF]

J Vitreoretin Dis
Stevanovic M, Koulisis N, Chen T, Moysidis SN, Burkemper B, Toy BC, Rao NA, Eliott D, Humayun MS.   +8 more
europepmc   +1 more source

Foveal Serous Retinal Detachment with Inferior Staphyloma: Long-Term Treatment Response to Anti-VEGF and Photodynamic Therapy. [PDF]

Yonsei Med J
Jun JW, Jeon S, Park G, Kang HG, Lee CS, Kim M, Kim SS, Byeon SH, Lee J.   +8 more
europepmc   +1 more source

CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS Study. [PDF]

Clin Ophthalmol
Chakraborty D, Sinha TK, Sinha S, Biswas RK, Maiti A, Boral S, Das A, Mandal S, Bhattacharya R, Dan S, Rungta D.   +10 more
europepmc   +1 more source

Genetic Factors Associated with Intraocular Inflammation After Brolucizumab Administration in Patients with Exudative Age-Related Macular Degeneration. [PDF]

Genes (Basel)
Yoneyama S, Sakurada Y, Shijo T, Fukuda Y, Kotoda Y, Kikushima W, Mabuchi F, Kashiwagi K.   +7 more
europepmc   +1 more source

Usage of brolucizumab as treatment for wet age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV): A narrative review. [PDF]

Medicine (Baltimore)
Jezani SN, Bastion MC.
europepmc   +1 more source